Patient Capital Management, LLC
Sector Allocation
- Healthcare24.7%$742.1M
- Financials21.6%$651.6M
- Technology17.4%$523.3M
- Consumer Discretionary17.0%$511.1M
- Industrials8.9%$268.3M
- Energy6.5%$195.5M
- Other3.8%$112.8M
- Communication Services0.2%$4.9M
AUM History
13fpro.ai/research/fund/patient-capital-management-llc-1854794
Conviction and streaks
Concentrating · top 10 = 52.1%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q2 2026
RPRX
$201.8MC
$196.4MGOOGL
$187.9MUNH
$182.0MAMZN
$162.3MNVDA
$142.0MCVS
$127.8MNCLH
$127.3MQXO
$123.3MET
$116.3M- PEOPLE$112.0M
PGEN
$108.5MUAL
$99.5MCROX
$96.4MMETA
$96.2MCHYM
$83.6MADBE
$74.0MSDRL
$73.9MGPN
$68.4MCOIN
$67.5M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/patient-capital-management-llc-1854794
Patient Capital Management, LLC 13F holdings — Q2 2026
$3.1B portfolio (+11.5% QoQ) · 40 holdings · Q2 2026 13F · top 10 are 52% of the stock portfolio
Includes $40.9M of put/call options ($0 puts, $40.9M calls), which 13F rules report at the value of the underlying shares, not the premium at risk. Stocks alone: $3.0B. Weights use the stock portfolio.
$201.8M
6.7% of stocks
-1%This quarter+10.6%Since filed10+ qtrsHeld$196.4M
6.5% of stocks
-0.7%This quarter-12.8%Since filed10+ qtrsHeld$187.9M
6.2% of stocks
-2%This quarter-8.7%Since filed10+ qtrsHeld$182.0M
6.0% of stocks
+0.1%This quarter+2.9%Since filed5 qtrsHeld$162.3M
5.4% of stocks
+4%This quarter-6.0%Since filed10+ qtrsHeld$142.0M
4.7% of stocks
-0.2%This quarter-4.1%Since filed10+ qtrsHeld$127.8M
4.3% of stocks
-9%This quarter-2.6%Since filed10+ qtrsHeld$127.3M
4.2% of stocks
+5%This quarter-22.0%Since filed10+ qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 3 qtrs in a row$123.3M
4.1% of stocks
+5%This quarter-29.6%Since filed8 qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 2 qtrs in a row$116.3M
3.9% of stocks
-0.1%This quarter-0.8%Since filed10+ qtrsHeld
All holdings — Patient Capital Management, LLC (Q2 2026)
40 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | — | PEOPLE INC - COM NEW | — | $112.0M | 3.7% | 2.43M | -10% | — | — | 13F |
| 12 | PRECIGEN, INC. | Healthcare | $108.5M | 3.6% | 19.04M | +7% | 10+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 13 | United Airlines Holdings, Inc. | Industrials | $99.5M | 3.3% | 732K | -0.1% | 10+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 14 | Crocs, Inc. | Consumer Discretionary | $96.4M | 3.2% | 799K | -5% | 10+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 15 | Meta Platforms, Inc. | Technology | $96.2M | 3.2% | 171K | -0.2% | 10+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 16 | Chime Financial, Inc. | Financials | $83.6M | 2.8% | 4.08M | +42% | 3 qtrsAdded 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | ADOBE INC. | Technology | $74.0M | 2.5% | 361K | +21% | 2 qtrsAdded 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | SEADRILL Ltd | Energy | $73.9M | 2.5% | 1.95M | -9% | 10+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | GLOBAL PAYMENTS INC | Financials | $68.4M | 2.3% | 942K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 20 | Coinbase Global, Inc. | Financials | $67.5M | 2.2% | 462K | +7% | 10+ qtrsAdded 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | Fidelity Wise Origin Bitcoin Fund | Financials | $62.2M | 2.1% | 1.22M | +244% | 10+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | BIOGEN INC. | Healthcare | $61.3M | 2.0% | 284K | -25% | 10+ qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | ILLUMINA, INC. | Healthcare | $60.7M | 2.0% | 345K | -37% | 10+ qtrsTrimmed 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | General Motors Co | Consumer Discretionary | $48.7M | 1.6% | 632K | -15% | 10+ qtrsTrimmed 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | UBS Group AG | Financials | $47.3M | 1.6% | 954K | -23% | 10+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $FISV | FISERV INC | Financials | $46.8M | 1.6% | 954K | -2% | |||
| 27 | $EXPE | Expedia Group, Inc. | Consumer Discretionary | $42.9M | 1.4% | 168K | +0.0% | |||
| 28 | $OMF | OneMain Holdings, Inc. | Financials | $42.8M | 1.4% | 702K | -10% | |||
| 29 | $BIIB CALL | BIOGEN INC. | Healthcare | $40.9M | — | 189K | +9900% | |||
| 30 | $DAL | DELTA AIR LINES, INC. | Industrials | $40.4M | 1.3% | 431K | -22% | |||
| 31 | $JD | JD.com, Inc. | Consumer Discretionary | $35.1M | 1.2% | 1.38M | -2% | |||
| 32 | $SOFI | SoFi Technologies, Inc. | Financials | $27.0M | 0.9% | 1.51M | +14% | |||
| 33 | $TEM | Tempus AI, Inc. | Technology | $23.2M | 0.8% | 401K | -9% | |||
| 34 | $JPM | JPMORGAN CHASE & CO | Financials | $9.6M | 0.3% | 29K | -0.0% | |||
| 35 | $GENI | Genius Sports Ltd | Communication Services | $4.9M | 0.2% | 813K | New | |||
| 36 | $NE | Noble Corp plc | Energy | $3.7M | 0.1% | 100K | -93% | |||
| 37 | $PLAY | Dave & Buster's Entertainment, Inc. | Consumer Discretionary | $2.3M | 0.1% | 204K | -82% | |||
| 38 | $APA | APA Corp | Energy | $1.6M | 0.1% | 50K | — | |||
| 39 | $LEN.B | LENNAR CORP /NEW/ | Industrials | $1.1M | 0.0% | 13K | — | |||
| 40 | $SPY | SPDR S&P 500 ETF TRUST | — | $792K | 0.0% | 1,060 | -5% |
What changed in Q2 2026
Against the previous quarter's 13F: 2 new, 12 added to, 24 trimmed, 2 sold out. Share-count changes; largest moves by dollar size first.
New positions (2)
Added to (12)
$FBTCFidelity Wise Origin Bitcoin Fund+244%
now $62.2M · held 10+ qtrs
$BIIBCALLBIOGEN INC.+9900%
now $40.9M
now $83.6M · held 3 qtrs, 3 adds in a row
now $74.0M · held 2 qtrs, 2 adds in a row
now $108.5M · held 10+ qtrs
now $162.3M · held 10+ qtrs, 2 adds in a row
+6 more in the Excel export
Trimmed (24)
$NENoble Corp plc-93%
now $3.7M · held 5 qtrs
$ILMNILLUMINA, INC.-37%
now $60.7M · held 10+ qtrs, 2 trims in a row
now $61.3M · held 10+ qtrs, 2 trims in a row
$UBSUBS Group AG-23%
now $47.3M · held 10+ qtrs
- PEOPLE INC - COM NEW-10%
now $112.0M
now $127.8M · held 10+ qtrs
+18 more in the Excel export
Holdings by quarter
Every 13F Patient Capital Management, LLC has filed, 18 earlier quarters. Pick one to see what it held then.
Is it too late to follow Patient Capital Management?
Q2 2026 13F filed with the SEC on Aug 13, 2026. Prices are closing prices as of Oct 26, 2026.
Average quality of Patient Capital Management's top 20 holdings: 64/100 (our AI quality score, weighted by position size; 16 of the 20 are scored)
Top 10 since filing
-6.3%
Value-weighted move of the 10 largest stock positions
Turnover
7%
Last quarter; 26% over the last 4
Top 10 weight
52%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
90%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
Patient Capital Management, LLC disclosed 40 positions worth $3.1B in its Form 13F-HR for Q2 2026 — $3.0B in common stock plus $40.9M of put/call option positions (reported at underlying notional value, not premium at risk), led by $RPRX (Royalty Pharma plc) at 6.7% of the equity portfolio, followed by $C and $GOOGL. During the quarter the fund opened 2 new positions and exited 2 — including a new stake in $GPN and a full exit from $IBIT. The portfolio is most concentrated in Healthcare (24.7% of disclosed assets). All figures are sourced directly from Patient Capital Management, LLC’s Form 13F-HR filing with the SEC under CIK 1854794.
Funds like this
managers whose biggest positions overlap Patient Capital Management'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: Patient Capital Management, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Patient Capital Management, LLC (SEC CIK: 1854794), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Patient Capital Management, LLC's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.